(Q41328068)

29 September 2017

1 reference

title

Selegiline and mortality in Parkinson's disease (English)

1 reference

29 September 2017

2

Fahn S

1 reference

29 September 2017

Olanow CW

1

1 reference

29 September 2017

Langston JW

series ordinal

3

1 reference

29 September 2017

Godbold J

series ordinal

4

1 reference

29 September 2017

publication date

1 December 1996

1 reference

29 September 2017

1 reference

29 September 2017

volume

40

1 reference

29 September 2017

issue

6

1 reference

29 September 2017

page(s)

841-845

1 reference

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410400605

Crossref

reference URL

Selegiline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410400605

Crossref

reference URL

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410400605

Crossref

reference URL

21 January 2018

Identifiers

DOI

10.1002/ANA.410400605

1 reference

29 September 2017

1 reference